<SEC-DOCUMENT>0000000000-25-007513.txt : 20250905
<SEC-HEADER>0000000000-25-007513.hdr.sgml : 20250905
<ACCEPTANCE-DATETIME>20250716163607
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000000000-25-007513
CONFORMED SUBMISSION TYPE:	UPLOAD
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250716

FILED FOR:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIXTE BIOTECHNOLOGY HOLDINGS, INC.
		CENTRAL INDEX KEY:			0001335105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				202903526
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		UPLOAD
		SEC FILE NUMBER:	001-39717

	BUSINESS ADDRESS:	
		STREET 1:		248 ROUTE 25A
		STREET 2:		NO. 2
		CITY:			EAST SETAUKET
		STATE:			NY
		ZIP:			11733
		BUSINESS PHONE:		310 203 2902

	MAIL ADDRESS:	
		STREET 1:		248 ROUTE 25A
		STREET 2:		NO. 2
		CITY:			EAST SETAUKET
		STATE:			NY
		ZIP:			11733

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SRKP 7 INC
		DATE OF NAME CHANGE:	20050803
PUBLIC REFERENCE ACCESSION NUMBER:		0001641172-25-000208
</SEC-HEADER>
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.pdf
<TEXT>
<PDF>
begin 644 filename1
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M%@((.$38R"9Q(OBJ;.U3$1$1$1$1$;D1Z7RQ%M@AM0LT@29:1<TM0I+3-&;
M]:./]AE[Q;?/!Z)\=08Y":$[GYZ>8E^">3;G$H>CPL<#[)6.*FQ!A<BOJC:R
M%E"4TXE>&@;\%!$1$1$1$9$O(F-6K(7E7$I,RZ%\\?CX&%NJAD @S=@2Q:KU
M OE/XZOTUT S28GCY<AK@2VQ(RK'W9%L#/OB>,*Q<"WAU%*@B"UI4U%KJ($Z
MJTJ#=D'XT/R6X)_#Q*PB(B(B(B(B<ELRP<>62 Y(!^E_4<T/8E_R<9 -I-DQ
MMD3)-&;@<%';T]/3-?X742V"!EE9:^5-SE.*I6D'2D63W"0[!%VET2YVG[U=
M.)?AR8J(B(B(B(C(K2 $)?$MMV30P%ZBFB7LCDE12>01554-A$":L05+B?B+
MYT@4N'G"#BPZ\G T9K_?/ST]97N04'X=0-G(9J>$0NR.S$O"=C*NDFHDCXA%
M1YR^\H6(B(B(B(C(5Y I1;;[/F1,C/U^GQ$MT@8CZDE3AUCRDZYT: 7Q#32&
M%M':V)*"R?/S<[0G3C^=5O@J^B1VP3^%'4EE0GB-/EZH\H6(B(B(B(C(%Q%K
M;8)7I"$!4L9\#1XK=S0*EO!('W7Q3OA-PD&09O0K3"RV4]M#6(SGY^?J]Y':
M!>V,$R%H9VH73P<(Y4$BE;<#60GY2LR=*B(B(B(B(G)#,@](6ES$ IPM^_U^
M;B 1JWC<*+!&J E#\=? T*(:.?P-Q$D]/3U5!8/FQ79./-K,!TX_M0OT#>PT
M\*^I=B94CCF*UA<B(B(B(B(B-R'3A:3%!;$=]OM]YOZ8Q,_,'!^Y_%^.*47^
M?O.#:' TFSB<C8+!QLR4FMH%\@7J1*H6L06/F.Q#K2]$1$1$1$1$;D(LS)L8
M%QG,(?^-=7HLR>/O<'>6\!D $T\3ENW79 SY3N(LT@8C[4;8V 3G1*D@>B?_
MIME)0+;6S+2"?$%8C#]U:B(B(B(B(B+_.GUP3E;<V _41?W0?R0*UY@81*JL
M;B/_%AE-M,;KX"NZA5B=&94TSK2:5="9L3&W8)ZQ,6F+B(B(B(B(B#2@2\3*
MNFY\>WO+[*7X353JPKQ"Q Q$CW]ZG1ZGCP<-Z47J]O0!R=YH)!J2L:;9!AO1
M<VHJ51$1$1$1$1'9 FOJC.<0?].F ON!1K*(C82PZ&TJ\*'X2;$=HG/P"DF3
M"4Q0R"V2"4=0;- E$#V0.Z*+JO')X^,C!AM_\(Q$1$1$1$1$_BUB6?WK0'I&
M8#5!ME."8!"!D\2FK-^C,/_6JD@8^J^;6_1DTMCX6SUET"YB(__B/T*0S\;!
M)'4>NK=&QA 1D>_AHW"R0%]F_NW)0PR_XF7!QP;>#ZPU9HT^.]BD\,9NG$"N
M\)<#,<RM94+G7#:VOZ_A9+//JG]CYTSVJKO'5W'B]$#-F2XB(B)7$J,JV4-R
M(,8P((-/YK#+$/Q1EN3Q;>Z%U4'=\O,@Y0KQ.=GR<0A/BKT*WZ891A9(7YOL
M9#;6OA41D:_FXR#%[P^LA1["4@X:A1D1.[\=FL_50S0%UHX>U1(;:@O9I%K;
MG"9&=',6?>&8 PS#<9^$F%<9%*O::E)G;09O.BYH?^Z>!8:MW5Y_6IPNQY<+
M6_9J'&S9-TYSWWG7$J8[;H8U&4=$1$0V@DM(3K&(Y!#C[]N!V)[6 CB#[ _S
M,=PHTMX  >0G^8FL0;S-&K,B0Y+FA"U=9M):@]D+Q>@B\JZ:=D1$Y#M)<;Y?
M>P)* F7ZYW-=F:X]P!E5ASZ5>?0:$[O&39K3U-E[= [)D1H^CIG0YP>*LSOK
M343-%9Y#7K-E7[074G=M;/]0N\@"0R/&[?5'JVK]&7][3N9?RXM8>[4__=UA
M;H YZ_9>%1$1D81U=T[A< -A1(YQ/U\,Q00F-L;,)&=*U3$DOOU?C<@(-;N#
M<06G'#U3DY)\''UJ]I\M+FKW+H=75+MBH2$B(E]-+FFOURYV)0A2Y0+M(I:]
MCX4\"A8+2=1<Z\S:D!I^K] TLFH7\=53(2HDDE4>?>/["*8!62>^$KA.1+6I
M!E05(J8?4;*>6AX7VX_<WL\NJD%C+R,,Z\\QFF;4^IO^R=8R7J_U:KV"2]&1
MHF%QRG'B]  3I^P<?45%1$0N Q.+^L:!(9OI"E.1#.] !(Q<I*>)9GQ@I/YC
MI_$GP%BWF;A&7Z5P@=5QSJQR&L.T.><\\<' %R(BW\9MM8MA/>=J%TO)155K
M&!:K)1L;DK7(#(W^4+6+WMLBOL4A="+.]*3+Y'XE^QAUUL,UU5:UO^FWO@%Y
M.*[4L*O[O?*D>E^>^F]J%W3^QEZ=M&0YNJ(,-181$1$YR<<Q(&>.LS&IR,D8
MAITU/2A"!ZI%>JUB(_I_$RX29C@U^<CK@6HZ2Z?1U3%?8MH<74H-S"$;@U41
M$?DB;JY=[#KSN0NTBX8U[6*MMK5S&3+7+B!'L8TQK+)7)VK\7*6?:!=K[<?@
MDUVVR *I7<RC>:1VL7UN0^2KO&1#8Q5>"6VL4$1$1"HQ*+.:YE\F T$.[CEV
M8_"9OIPYE<+?Y'\K7$!C?=$X_.(OS!;F,\3XJA,;"IPU\Q01D<NXB7;!JKD^
M[:O(\/W:!6--!2%]N-<6[2++U'G"A/KN@[V(CH7'2M0PS!52V:Y=Y+&(?IF3
MEI/*P+G:1;2\[]6UH]2Y4X:W(JH5+B0_/AJ8B(C(%Y%1S=-@H 8\KX&JT@FB
M28W!(GT^K?J?0'=5-Y!\_42 TWQ]0[+4?E:&CJ3GB(C(5W,K[2**(>#G<)EK
M_._7+G8E.&2R]F9ABW:Q=*X3<T[&_\3^<+)^WZA=Y(%R K/=^.1<[6+8JVM*
M3DTT-F2_DIA&1$1$)J2W2+X^("-8+5.G9$S V,+$ \?5_[G%1:61+Y@;,TN)
MSR>G*WJ.B(A\#S?4+I;/8V6. O]#[6(I&4+ONARI=?V^)E]LU"[2N+$F(I_'
MFDB^5+M8#E.CWGBU0?E"1$3D+!J3B;>WMSH32VJTKCJ!P413'X=*3@5S6L($
MABXEL.=\^H=)AG*0B,B7<EOM8OG\PIW'^/=K%S'BO'XF!OIK?$:6B\(^+(?>
MX^C1+23RB'KJ7&*MMHW:!:VB;]^/Y.G,HUZ<JUW$A^V]"M&WY!8)R-M2L\;L
M5O*]BHB(R) 8-'\=2$^0',UK]I LG&,NTSR%BS72ZY:)#<8M.5W9DDPDYCD;
MHZ*)B,AE;-$N\M&]1;M8.NN+B1G OQ*K,W.>;O=GG"_)3\H+6[0+$HO/F8RA
M7Q>K$R8]D#$Z'.5%1$2VPQNB')&9<57WD":1.DORG*=A3N!;@R%,3E*F2.4G
M\\S.04<RAYJ(R->19A)K8UG-O[E1NU@Z^>*?UBZJ]C[Q\FB(><5$$\@SFDA&
M)[6+K&3?D9T_Z8HOU2YBE&^F3Q5,*X=WCHB(B Q!B$B3Q?@W1G!,+JN1  E2
M<Y<HST!/6/4ZJ8AZG@\X%@.3WIP21[?$Y&>[U(/Z8=!.$9$O(G,_[8Y. 1]'
M>&+7;_O=U[2+961]\0=]1AI/A]K:JETP?"?1.;&E1MV<+_,3E <"<I)4/7LU
M/J>MR\2*XZ1VD<O_H3J1)ADUEE?#]3XC3:_6P9U+%J>0647RIHJ2U835MS\B
M(B);8/Z0HS81.PG]34:,ZC]"=K"T&6!6UHSX.<3C2/)_4S!P[(W98YTI9=;4
MC374:0QONS2]$!'Y.IH0E_GNOH9E6'/TFV@7RRC,]=JAOR%69]+83E3MXNZ0
MS#1IM)?M"^U&MR%!:M^K$\N$D]I%1A%9DR8:%]>>F\3J3&KDBNI^NRLI8IO3
MWV[$(B(B\C^'L37SB>0K#"#(9&. L3O&E<)@HUE3XQ,1&V-?9!!F)O^'H3E?
MST&U/<X)V-S<-+ZETZ)P=%I.I;@N&U]UB8C(N<3CFOA"NQ4P8QCNF%$@UE;0
M=0SM0TC5=_J3%IY;;$ZO7=3HD3TLS,\:AC#8R)G L$OG*38RPD;?;TN)%S%9
M_J>2,QQ#,QW);CHZGTSV6GNUCON\R%CK6!QR_P^S(Q$1D9O 6CL'=,P[L6SD
M;U-R=YR>90;/-1-9YGCQ]^'A@1<WL?VG6D5&)^ [DZ8I\6_C-TWJEKMC2MF&
MZ*A^>E.3C/P^\$WG(R+ROX2Q+T:KAR/Q,(]_&?6&NZ2;),6&9:@3&@$$^T:^
MFB@#%Q2;TZR:X_.D<+1YT@-S>--1>Y4NQ3%GOB_JQ[#?EH-VD=^N*0"U3-]O
M]:PGCIGU$D\@ATA_4OC(T.?T0+J0S$]?1$1$$MX6I8EC?87Q/'H5POL+K%6?
M#S$<UB)ZL8IG9L)HCF'GVGNK?YI4=5 MEF,/]&:]=,+]_7TSMZFNUKN#82WQ
MS2C/] :_W9_7>R(B(C^#G_J"1D1$Y(]#I(LF_T4UYFQ6RE@_\@9ADA257'+(
M%\2M(K5]_.40!-/XCC/\8J)#,"F)L\N^2HN4X<L7[$ZK-%1[OC&@Q98X7^3%
MMT:]$!$1$1$1D?\5Q(QBB<UK_5B#-PI&KITQK63'*+;F^["4&!JX43P?7$6>
M#TZOV$QB6C T[?A7B'//^.'1=4]/3\]'CQA\C==BJ='/U9TD Z'WMJ9H'>DV
M0M0+L\"+B(B(B(C(_X27EY<:3H%P6*RX8XW<A*6J.<A8:\^5A^=#R L\0 GP
M%2MNXE424H,*:][5?P5TF)1?\.S@+&I$]$G4+\2-M%K!^F58/KUXTC=G8NXB
M(B(B(B(B\L.(%71-Z)8),A E6*$WZ;V(7['F$-&01A<LP(G_@.4 4@8&&'G$
M?X+JWY%QMS)=+.GD./&))D-TBS1<0;OH^Q/9!WTIOV6C'K4B(B(B(B+RXR$D
M1?HU$(PB5L3XC%2OA!J(<IF&Z.P/D3O&7KGD;U*R9@2,OW\]7KU="'-!IT5W
M8:9"@,W=J01V617%D#)Z 0>+CL8QAT@C_Y#:(R(B(B(B(G(9O.O/I!BQ](X5
M,685?12+FNUBO]]'R2V'P+6$13U!,VJ2=U;]F30MMO_-\D6<.XX>1!F-=B+@
M$/4B&A_=\G(@$ZR<K)"27 ($HJB$1*A4M3_2!/"\/_#7]I6(B(B(B(C(38@5
M<=H&Q/*YR<[9R!=/!Y9C^(4M1A?+<7D>2WODBZB9-.N$N<"W(C.HXF<1V__"
M_"/XN:3_2W07P@)MQK"$""$4JYXX$S"]R. 56%G0,[L1&<D3A<2(G2(B(B(B
M(O*#83&>P2&Q*&@B<_+V/];@\3==2S9&NDBP[HB]6.93+38>42UA)SD$?B4L
M_/^J53FM(J8HC40ZR([""@)'&'Q)-L;2Q%4D#5J ;JD7@IH)<)K6%_-8H"(B
M(B(B(B+_.B@)*4&0A3-H<HLDL7TY^H"<NV1.;X@TP(!8[Q/L@O :*"1H'5%^
MHVG'5X-I!#8/T6",+C)P!^>5$3#B=- 9MFL[3<*1Y7 MT@"&T*;Y51R""[$<
MO'CRLXB(B(B(B,C/@Q *^6]=:[^_OS\]/>7R'% 26&A?<#C"2^(J4D->H%K@
M:A$'S;B=?X-\0=A2S"JP>2 &!685:1J!?(&JD-$PMA\%.2AJXQ+@O(,2T@@@
M\2\MX5^L0?Y"_QH1$1$1$1&1ZR'#R%P9B)5R%$"LP$*#Z)0GTV>LD085^3==
M+>(K#A2?40#0"OYL[E2$B\P;DJXBT50<9]*A(Z68"PPA,N,J9\JQ^CB?A->H
MAXB+:+81$1$1$1$1^:G@Q)$Q)6(5C.5#3<=)!A#L)?!H0'PXF3YC#0P,8@T>
M]6"T@#* 6$&&UFK,D!^V+\_)5?I:N,PL(2TNB,9Y?W__< #A E>.C! 2_Y)"
M97N8BX8,";(<[2XPNN!<:K<TBE/L8K81$1$1$1$1^9&PYN4SK^]K# JVQXKX
MUX%81Z, X+!P\4HYXU(2^*+:*F3(B'0G(:1GRA=;!)-H)]8:U=7E,LL$8EQ0
M&TW"O@)7$606-D9).@>3C,N<7+)GZ%MTI/Y<B+FQ% >?^'=C0A,1$1$1$1&1
M?P@L!#)O2'7E@%CLQ[>Q0L>TH-H#Y%X7@-T%.4#S6/LC43-K]OP*@24EB+45
M>FR/MF53XP->'MB-I-_']G:2PA7[BDSY@=["(4B2DFH&F@EE+A9V$&I2FN!8
ME:@\A1'RORQ'WY^++6%$1$1$1$1$_DZP$$B'$70#W!/Z3*FLFI>CQ''-*WX"
M.Z MQ(?J-H(9 \I#FEO$AXP%L2:;4%4J'M7E),TMB&FY,>DJJ6.14S(*!V)%
M?DB[$4A!XQKMHKJ-+,=@(\]'R%0;("OMCJE>B$!BIE01$1$1$1'Y89 =E<_D
M],1*82DY+ZH:P"M^_$>N.6XZIR +U'RI3?*1_("[2BH2C7)"( @L'ZK;"U83
MJ5T@@&P1%G"3H7!4FZX<NV,R$6PM:#;"!>>"GG!Q%%,ZAPK16+#E0+[ 4J7Q
M'\ECH?88\D)$1$1$1$1^$E@(\#D=1E /^.KM"+$ZE\.BGM@.UQRW^HSD$3&W
M((Y$OT(G!RB-9-^L#44BML0'#!)2=NA]*+"F.!F, E6'?B!S:Z.E[(Z!.'!O
MR0]IE7&QAA [<KB:;61WS&/2ZS/U"AKR0D1$1$1$1'X8N4!>CD$I&V(13<B(
M6,6C5Z >7!:(,L&,(2K$.27=1A EL#2H)A]I]8%-PNYS0(EJ(U&%A?@[/#I9
M5$XV+\-<Y$$K6%FDEH)\0;A.S$BNZ1^JQ:""Z"(H,_&Y"7^1\2Z6HT>,(2]$
M1$1$1$3DQ\"BF*4NI@LX@_3K=$"[P"[BRI?[&;P"&8$Z,ZM(-?RH_B.80&1P
MC+I(IQBZ1\;Y3'>8!D)53.PBD [2H28M'U*F0,G!.H*4*-%4C$;8ZTIM![L4
MM)=H9]2/?%0O31R1]*FY%SXU%^12$1$1$1$1$?D[J8$K8PD<BVX6PK$%BX)T
ME  L$+!PN/+0K,V)=)&Z1&9')6H$+A+5E )CB70GJ?H WB+Y+VK#FF,+WT[D
M!0)99%*25!*PQ. KOJ5Y-!ZW$4I>:?R 8\[NF"DU4YRD>!)=$>?;RR_XSEQS
M:)%_!4.[7- #7]UI7I2_$Z_+#\:+*R(B_P=P;4B](A;FO35%?$MTA5@OX[.P
M^QQKXC)PRHBU?QPQEODI J1% 88--=5(:A%I5C$1'TBZL5: @!(3MPY,*7;'
MM!V<]>[HAY)A.2G#OU08?870<:7=Q?(Y4VIZUD":QZ2-2DHEM,29C/Q!XO>2
M<66!C$)QET[LM7@4O&P&?75+,Y 6TS**'^G:;R2:48\R$2&;DGWVHMAR\BR(
M(S3OEK6CI$76=N)Y\O)9\FT*] TXZZ($R*IK5X0"]8K0I!M&Z6FZ?8N,W)SC
MY/9H>JQO=G.]>DY>\2V</$I#='+:X_47=!@5JBDS_[U@A;C]][[]5]9<S9,Y
MPOI+.2_?_P0FAZB-F=PD]1S[GID_?_I3WG)Q7ZZ8;V0[ZQQCRQ,[(0=]4P-/
MVOGU8L?F>DUZ9LMMV??>I W][Z@OW-PADSN*TV%F6/N!GMPR*^N'SHU/R-HS
M)X\U'!GQX)X?I>_;2?FF22?/741D"^0AY3->$HQ9^;#-YU(\Z"AYJX5Y5I5^
M%JQ$L*D@&2A&#E738*G"LGWNMS+7+I9#<(^H86U02P\4?$9JO(M4*K)M^>3'
M$(*]-J9AG8!%"MT>-2-B8%Y"3,YJ$I-Z!8.FX3KECT"PES6G,WXL^4MI]HV?
M3/VQ;V%-NZ 9S6^DDM%I^LEJ[-L_<X:0F"DK[)\VM< $'BEI]C8_2O4(JVFC
MM]/44,7AH2@]C(,T8?ADC@/U3ZUFKWAVQ;6X7G=]^>SB=S*L- _MNLM$_JVW
MQ_!,TZMQ E<\#GKQE+ZFW-I(WLE]*J[FNG.QF@)]AV"K.6\&I]DO7IH?^\3/
MD=C:V6\GYQY1U?"L)SW9_(@FN[P<<LI3+&[7B<"UI6<0E/I;J!YE"Q?[J'*A
MY\^0M2M86SNI@>CB:Q,2U-?F<)/92_,['1;N>V_^#&^BK_>W8ARB?X/6P^N_
MR34B=MS'@6%7G'Q"DO"NKX'[+4O&@2::X<D!>OYC; R )S=>?8:<_!F*B&R!
M(3LG+2S&,1ZH3R<\./)1R=AQJ]?ZC4\*,SH^8W>!_ER?DSDS.3DCG3Q763JE
M2T@/9B'T!N-%TTY,'6J\"UZO(*K,@VELA#/%.(3Y\+[+O5(O$Z,58_'URHG(
MN?3KJ;LCS>W*+[V?7S53TY,,?[_]TBQ;TM<P?$KD%/3D3ZDN8X>+N^81-V>H
MIM9*FL7R]=K%\EF:&#XPF^G]EK-HKFR_0ME-K\B5+^F:T,I;ILW->B=.8=*&
MO$O7$F%OOR@HY)<-%F?=6DT_- )+KUE5!6#8@4-=;O)[[RNIM\3\-43VYWY#
M<O-FL-ZRJ-^N7!$5G&)K2[Q)S_079?@8[.64.9=I%T.M>.T*[D8SKLGONJEA
M\H-JM*;)&Z7E\STS;-*P][9K%VMOQ/(AN=;5_46?_!9ZB]_A2+%V(8:=607;
MM;GQ]CMS36[JVSF9AU=S96>D(G(3F+WDDR<>[_EX2>/MU('SX<_R^2;:!=$V
ML)],T[(T-B#52%4SF-/FL_>DN>:NF[=@J8N*SOQV$KB#02W:@U5V>HOLCF\B
M4DE K\#&DK.X.Z1SO;)_T$\83"=OV1#S\V0Y<2WTY/NI$TM>WV >SP^\>=TS
MG//4141F#EICN"!J%J%WAV1&&%?0$F+Y9H'A\O.+M(O[$<WONG\BG=0NFHYJ
MWHOUG7:-=M%7V$!CFJ=??0''5>/&X(HT;ZBO=WEK; :V+'C[=[7[0W[P8>'M
MV@6WW]-GFI#+:[^%D]1;ZX(?"^/O\-+7*SX\QT;Z8*!\.;K#\"NKISE<H7^1
M=M$($1/KB+5=)GN=U"Z:D?KNF$QM[?FS5LG^LPOMR1_=N=I%O\!GGE.O8'UB
M#Q?U?5?7&AHK@C7YHM$N=NM2 S.B6G*C=C&\_: 10R[3+AH-.7V'ZV^A'J6_
MZ/4AW#PA7P[N/+4GAS?G2>VBZ3U>2M:C-(T<_O"'&LOD>N49J5V(R$U@?I*C
MR>39$H^F7(S?)%!GK1:/R(<CZ2>"S0/Q+C*Q2#Z?UR:-P .V'X881!AH,KWI
M9&*3HRH#4'WL8][,V$U3]P=W&^PG;Q(M,V=!7".&C/W1$;5?'7 %AZ*-R%=3
MIT:3]0(3VK4I8DZ&M\QV<"YNVM"\39Y8_O.H&1[E*[2+*+!62;/>:8XXUR[Z
M7WI][]P_)V/WIOZSM(LM3[;&V[HN)2:+")Z<E[U!K@QEWI.IEX96^FNKK;.T
MB[4[L)$.+D@.E7?%%JF\O^[+9Y$G3[9VX# D5%V_TPD3CP"67<-N_ KM8F@C
M=%+)'YI[#36TN7;1K)HGCT%>H*Q-I9J?S$GM97AQY]05*.G;AL5P9!C^*IN;
M9ZV&^G@9_OQ[[6+M?NY7S1NUB[62&8.]GL@%VD4]A34=DM\"1A>]QT?>5!.3
MW?3-&=[/<^VB>2I.W%[V4W_)-4O"-;4D.TWM0D1N L^Z#-0Y<9'C$<3#!Y^[
MFS2 .<G=,7P$;R&K4I$*!EN0"W@8SF=Z:T$Y.&)4DA.JX?.YJ6=7M O><=!7
M#&>\U>5U [8B<Z/'<_LG3X07=ENF,?.3$OD*MMBL MF%AE^=I5U,=M]-A0N(
M7\K:8^2+M(M)>^H,OYF:3K2+(7/M8G[HFV@7?7MR]TEX9 YT0Z.+&BOIY )P
M+<+ T/KB)MK%\EF^F/?,D+.TBR&-S3]+R]RR-I#5E=IDVI"'6!.COD*[R$NS
M+P9()W\%:ZYJ_8 [URZ:GCD9+W%-5#E7NSB7^JR>R(GP<8C6WK>AVF+-PU?6
M[IUW6M)/8(:JU';M8NC(UB_#+],NZB-T,C6E*_I3VRC[+X<+MU9@/OY6H6E^
MB&K;W-\;$R_(X7EEIZE=B,A-X%E7/^\.4U/B9&)E35 @YAB8E@WMM"^&QR#1
M0>MPPP#!NPG>TNZ.;P=XR$\&"/:Z.\38["$J!060P2=S@UZ[8"^L89MG.)H&
M:LQ-7#9RF&"L)!+4Y#T.Q9A<76:$+'(Q=>Y4+:6'83G7;N,MVL7D)>_<PGD[
MWZ]=U.G]OZA=K 6@6SI;98S3&$V&0>=.-GA"O0=J<*3YD+$4[0(WO>;!WMP#
MM](NJG1PP?1^BW:Q1>MN1M[\,!S%ZMUXY4A7M8N\&7JV+^3S3J-A)V,4)'E!
M?QW"@->KWT@0$^VB<1RX9K&V\92O%ZPN-G/:KE0OG25/<SKY(\6F-"]$8V"6
M=QW3MLFA:^_5B,V]SU0>M]X 5VH7U1>C'_N&E[)Y0N)^=>X3<G)%SAU!)E),
MK6K?A5]KCJMV(2(W!R66ST/I^^X8=C('T).&"A.&CUS6^WSU4;)EH2VD<,$3
M,N-.3*9,:8HY>50RG&5 /WQUAR5S3,%Y,[L%?\;,S,(121. 1<>MTGST>5JQ
MQ^[!L)//Q!>]20-$-M*G5^"GRD]X7[*P;5S"$X2_(>[SB;UKG?Y=<R[?J5U\
M'!)/US7CO)(_JUWL#V%,^HM"0.-A_<-7=<V-P73]^L=F78_P,*SO$.<O-#E'
M[/&:!C?O'V^E72R?WX>>NXIL<A_TUZ7F19TP?*,]\6&?K$//HFH7DW@=]:DR
MOXAY)R/RUZ;.?PCU@L95:)YCU8)KHEW4"+%7^M76U3=OB_J+RT_FRLHO-NJ8
MV(GUS)]@]3=;;\7ZG,^%^:3,\ 3Y%?2_XBHTU3*7:1>]U5:.?=S#!"5;2Z+T
M,0JY/'Q"SI]@N6_3+>?>F1ME$-RNF^A2]4>A=B$B-X>G,9\Q7FWF"16>2$RT
M+O#,C>%F.$KRD"2  ZN2*I@WJR&<)O@\'+5YKO8'ZM]C,CO%2X63&D[5JIE'
MCK $NTC= Y\1##/HT@OZ9PWF5 P??:Z35)9R"\,NKC=7OL$4.9<F1N(:*(?#
M&K;D&5G3+K:_9#_)5V@7:*3D3JHTL]:YB_$?URXFUW3241LSE;!,N_C!U:Q9
MV+A1'*C:1<9SKFVKSA$WU"[.>G_=L"7/R,87#<W+BXF!7PT1<"N%<#N3M7:=
M+>2(/S%GJC07M(\)F?+%1+N8]PP&)!M[9F.>D<NTB^T>"A/J$W++>56#NN9"
M5.TB77%WY;=3E_88)&S7+E!$>].+/"@SI2NUBV5SABRTEW[WC5EQF7 .+]E<
MN\BOMOQFJ];1/.(:[6+I'AU5OE"[$)&;P\.6SU@[,+R^'B O -X<^:RN^2RV
MDX\['E]1>7V1D6E&4V3.53F:0&8HJ/D^AD,,"X&TT_LX>!<RD,6A>:+REC!/
MGV4^(GGS=*U#'J\Y\CE,.VED!NI,)>'D4YJY\9:N2]..Y3CE>#[$KX8F<4..
M]4A :A?R_<PSU%>&JZH?K%V<Y*[+ -)7\H]J%TL)Q7FR'RY>3U5Y.3?.[=5K
M\YJ1I9<O\KWMS],NFM7Z) ;"7ZM=Y&U<(X=L_"WT%[3/)LFDY6+M@MN)"55/
MLY[]/VL758/B[DWYD=]O75EOL;M8RKW!(1IQHQ:X6+M(F]N35VWM.7_E$_*&
MVD5SAS2GV6@7RS'J?G^":A<B<G,(VL!G?"(>#^23F>1N]2%YF7:18U,<D6EP
MSD!X$A*H''.(YT/:D7P.(RSD4Y&O<I+96Q4BR_-L9[AA*,1/A)"D'!VA@R&,
M9V]]2J='R>YH 4))'$8R^QN6&\1?0FG9G=(N:$^UW)M,'N@ZIN+T#R\FAC;8
MV1MJ%_('^3A$YR,L3- ;?N<=V[^!.NDSPC-J>-QKEH$-7Z1=K%G"8V\P"5GP
M]V@7:SXC!%*>'X@G& XFB,9T13]=OTQZ6EM4;HFD-U3%UZPO;JA=5,'M7&?,
MDSXCP\" /1^?(W;FF0X+WV3E"_6@0[>(O+M..OZD0M4L+9O8#FNF%\,+VDMV
MT<G-&XVUGNE[;YC^)@LW)[719^2RGTEMR<7SA(T&+="8GS4/BD:[6#Z'V^W-
M:2[0+AK3BRJ&L,OUVD4>FD%J/O9-_ >)TW+R"3E,#EYOU*95]69;:WPR4>&&
MVL4R,KED*KYVT45$+J-J%W6PJ-:V^\^IPUGC;WP*,5X\'U)OL)I.BX4Z6/.$
M)[31\R'U>0:X8#LAUWC^T[9TV=@=DX\\E^ 5Z6F8CTUF+W>%7R4D5_U,_1E5
M8W=\VY+]LS\F0LU(%+0Y_N4<3\9PIMIT R&RTUKY1KMHE)S=T8&E<15'_U>[
MD+^!#,F"35=]G]C//+?$ZER[L1NOWBWW/PWKMV_4+JHQ\Y9X%RBT4+/1G3S*
MWZ-=3&)UGCQ0OTN],9JDC>=66*?N3?"$QJ)@S>)Z:-$WM+[(+==K%W4->'&\
MBPM^+)5Z ]2^.KDP/&ELDVV8_\IV5^<9:?)UKEW]M87;FAC56U]DUK/=*(QA
MG74T9T2_I:=J,X=IVK,Q),5E0_S'^=%6^ROXO"$K:-*H)9-X%WSU\3EG:--+
M%V@72[E#<FI7S_U6VD7?:3S?T#3JO;2EDLD3LK]GYD$JSOK-U@=",SM=TRZ6
MD?7%E5G#1$1Z&#WYG($L^@$7B2/U\+.>0CE,\*XM5>@Z?C6O&-*\(0-$XY>1
M@PZV![R+:=Y=IK-)?FBH!78KI O)W='YND8O9]91XW)4YIW#1"A%F/3XF(QB
M5;M8CNXV=8(TW%?M0OX4)Q\.U;&WGX!=.=NIL[LM;YS1'OOMM1F3GV=])SA<
M8GQ,8W76KIBLUO\)[>(D)Z_FR<Z<<)9OSO <)]Z(O7QQLGLW:A=U3;?1]KYR
M?8[4Y?--B/%&_CL97\ZZP9Z/?IH-M](N-GI8P/ ^G!C23!RF^D?')$<S$XE:
M.%?3%VL7%U.EGBTZ(79T=4OLDC6<E%X;:[JF0*]=+)_OL=UGG>$R[:*W>ZF/
MLNNUBRV.P',CJW.?D,VW<[/#VI_S9WC5ZWJA8Z)=+.L!K]0N1.16L Q?CGGE
MUNP/F3FDX^&YVD4Z9>1ZGX&L/N>9+Q%S@_12F=<C32_Z]U.\PR7<Q*Y$S+B&
M?-)B&KT<Q@N:C?#2.(SDQBA<[5AZ,-N[*YE5T_QCTI^-W05&)FE8F"E9<<:I
MX[[:A7P_>.S.GP]U>M-/?L[5+IJ;O%EH3 (_XGO%;["?<]9&3BRI3B[BYMI%
M4\/:Z\M_3KM86UW.X^37HYSKC)"+ @3GGCI\]&]^EZEVL:S+%]=H%TV=%XA"
MYVH7?4N&5[;>_,.?85T\LN/:T7G=S*^L?[]_*^VB6HV>O/K#2S9W NJM+Z"?
M,C7/GTG/++?6+L[5^NH931R^TF"@7[,WB4&']AO5P6JW\M)_J%TT>E3]=5RF
M72S3&_MZ[0(_D?G/<&)DA;0R3\(UE_WGVD4CW:S=F4V2G;Z>N7:Q'"?SS2]%
M[4)$;D75+G;K41J8.? 0NT"[8.##F8*G(L_87KO ?Y,AH+$]^W7PC,@\(TQ0
ME\,#.1K#L/)K/<G:=G;'9-\TK]IU[XX6(&DO@6T&I\;9358*_>R72N;NAXUV
MD3W9VYWNRN)([4+^"/P\?QW"R_1&7/%KJF:EPR=)U2Z>#Z%O)J!P-C4T+^S0
M%5'\>/6)$-I,Y)I*FM"%1+RI/R@>.XU.TG?(2>WBXW-VO.'\_Z_2+J(E\XO"
M56X:R:H!E?6IRQ5XF4%U)?MPS=CFXW-(AW[5.=<NEA7Y8HMV41V%\B;$'[,^
MNJ^T,L*[? +O!=;.:/\Y?>1)_YWF!2MO-S)_=U3%F_IZCOU(=Q/M8FVANE9F
MZ"5Q,H#), W$\'!]SS1/PH]C.*!?ZVX4C6,.'K7SBWM!%++&EZJ_@LU=VG1^
M(R_D%([6\GJEL8=96^T.^Z%Z>=1?Q\7:15V_-\_\*[6+O$49^_ITSTUD]7XL
MJ$_('+!JR^L3<OBJ\62XI^?/"4'RBG,+54O@25><U"Z6D?6%VH6(W(KJ,X*C
M!.-.=;++P X,]RP]MCA(9K4$'6*-C]4!3[9F-*\!)3 GH"0C D,S]51[MHS:
MO;L%/+<YN[>C) +1& (HU<G>K\^^)Y,7K_1J:AWUH(UE:4.O7<S;SP"A=B'?
M3V]<7=VXFA_+FJ'7N;_EX8^N416R)=!L9Z[83](:#617LA+W]:S979_4+I;/
M.LG)Z>(?URYVGT,B#.G7&LV#:W)C[,Z/LYJ3]GGG-!%'U_QW)I7TGBDGM8O=
MYWNOOW-VYWC0-YR5PF;W>;U6Q9Q>.6F6I</37'O!.CQ'),2F8V^B731)*-8J
MJ0NW7D4YJ5TL(^N+-:FD?XA-[O;=*&_F65XP<&Z@UV5%D%F[@BQUY_=)K:3?
MLM9=:]I%7O<^\N1EVL52)E3-B5RI732RP&YZQ7L;E9L\(;>$JFY"4DQ H^YK
MV*)=+-W#0>U"1&Y%]7'(YQZ+:_C5^=:=FV<$(3=#7]X=<F%0.7I%5H7M!T9W
M2,&-40'[-B9M^9#?C::(%\#9]88?=T?[BO1/80M9#U!^AI(.8RCO(')$H]JT
M(9EH071X:A=]JQI2N^CG>")?RO!%VY#]P7U@6,E-M(NX\YOW^$/B9SOQ8L!-
M>\M,;[_N)O-Q*I@G-+XGS>3Y;],N3G+7:1?#U$C#'2=N/D-JYYP\V7I+-(N:
M+=K%TEGB;=$NYJ!L;S_?RG;M E*[^#@FX8(M;VF'ZQ1\Q.8'Q?!@>$TOT"Y^
M=9%4\ZNYY-6,GDV?9TOFMU"SV)^XV0Z%G1Z<7/JGQ_=H%\OAIWWR+NI-1YJF
M]EIQ7\/)H%Z[D?T)8<UZ^[T\W-#3:J)=\-4D1O2:!=1<N^AM^=88_MXQQ.HC
ML?=PPPQ_356[F#B@G?S-WAWL9R;Z[4DCMZ;'=FH7(G([FO@,:V%VZESZ7.V"
M22^I1G;'J2FR,T^V?%?"U )_C7R \Q1E6,'*XNY@N4&9)D)%;'Q<![]7'%*H
MH?K#,K6^[_+$[8\AY;&XN#MF/Z&==0CH!XLZJ:YI4/I#3*9MG#O:$15B3]CO
MPJ1:[4+^+)C$9S"6M%)(=Z>)7/!V3&&\D;F7%BL(@M+\.L;IY1<=S=LXE1J>
M"U7QQ)C'<&"BF R?G"PD:S$2<=9*:K?,9XQ-;6NOSQ*B,6?YX:2W:=Z6Z](?
M%$,^_/[VW8V!E=T% 2<S!/3)DR4^TO!R?)24V?MCI*,MW34\8G^@!F(T1:_.
MW=OGL.H\ZZ)P<9N3W1]^E;U<UI39'VZ\H=,3:O^^_,KX=<Q/L&G_Y*YN?D1Y
M=9I&SJ,-, D97KCFL3.YA9J6S&TFN=MKWK3=\>4%,Y#&+V#2VBT7]S+M8CGF
MY1Q>P6CDQELTGY-I)[#E@;\<[7_ZBYO?]L],S''[ZYC4WNOOBAH9+!L_OQ7Q
MKCIYW>E)YHK[SX^X+9V9WF07/"'/^BWTO]ELY,F1L?X$YD>IEVD_THM$1"X
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M99V#SMJ*OBY"^Q<'O:5',P;]$>UB*'-5$6!C*J[:.6O2&1?B)J?&_= /XFG
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MYVR\"Q$1N2U,?K9,.;!"K',8WNGTE@/74(-7]]M)#$?<[W2YS2"6S9PJQ8J
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M,C@^/G-T<F5A;0IXG.W!@0    ##('_JW> $50$
M
M
M
M
M
M
M
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'"B4E14]&"@$!

end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
                                                             July 16, 2025

Robert Weingarten
Vice President and Chief Financial Officer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
680 East Colorado Boulevard
Suite 180
Pasadena, CA 91101

       Re: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
           Form 10-K for the Fiscal Year Ended December 31, 2024
           Filed March 24, 2025
           File No. 001-39717
Dear Robert Weingarten:

       We have reviewed your filing and have the following comments.

       Please respond to this letter within ten business days by providing the
requested
information or advise us as soon as possible when you will respond. If you do
not believe a
comment applies to your facts and circumstances, please tell us why in your
response.

       After reviewing your response to this letter, we may have additional
comments.

Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2024
Item 1. Business, page 4

1.     In future filings, please remove all statements indicating that your
product candidates
       are safe and effective, as such determinations are solely within the
authority of the
       FDA and comparable foreign regulatory authorities. For example only,
without
       limitation, we note your statements throughout your annual report that
LB-100 has
       been found to improve the effectiveness of anticancer drugs, as well as
your
       disclosure on page 9 that LB-100 has "proven safe in patients at doses
associated with
       anti-tumor activity."
Description of Business, page 4

2.     We note your pipeline table on page 6. In future filings, please shorten
the length of
       the arrows in your pipeline table as appropriate to accurately reflect
the status of the
       product candidate. In this regard, we note the arrows in the second and
third rows of
       the table extend through the end of the "Phase 1b" column, which may
indicate the
 July 16, 2025
Page 2

       Phase 1b trials have been completed, but your disclosures on pages 7 and
8 indicate
       that the Phase 1b trial in patients with metastatic colon cancer is
still enrolling patients
       and that the Phase 1b trial in patients with ASTS is still ongoing.
Similarly, we note
       that the arrow in the first row of the table extends through most of the
"Phase 2"
       column, which may indicate that a Phase 1b clinical trial has been
completed and the
       Phase 2 clinical trial is nearly complete; however, your disclosures on
pages 8 and F-
       32 indicate that this is a Phase 1b/2 clinical trial and that you expect
the clinical trial
       will be completed by December 31, 2027.
Clinical Trial Agreements, page 7

3.     We note your discussion on page 8 of your Phase 1b/2 collaborative
clinical trial to
       assess whether adding LB-100, your lead product candidate, to
dostarlimab-gsly may
       enhance the effectiveness of immunotherapy in the treatment of ovarian
clear cell
       carcinoma. In future filings, please file the applicable clinical trial
agreement as an
       exhibit, or tell us why you do not believe such exhibit is required.
Refer to Item
       601(b)(10) of Regulation S-K.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.

       Please Jessica Dickerson at 202-551-8013 or Laura Crotty at 202-551-7614
if you
have questions regarding the comments.



                                                              Sincerely,

                                                              Division of
Corporation Finance
                                                              Office of Life
Sciences
cc:   David Ficksman
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
